115 related articles for article (PubMed ID: 26406953)
1. Matrix-remodeling associated 5 as a novel tissue biomarker predicts poor prognosis in non-small cell lung cancers.
He Y; Chen X; Liu H; Xiao H; Kwapong WR; Mei J
Cancer Biomark; 2015; 15(5):645-51. PubMed ID: 26406953
[TBL] [Abstract][Full Text] [Related]
2. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
3. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients.
Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B
Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer.
Yin QW; Sun XF; Yang GT; Li XB; Wu MS; Zhao J
Int J Clin Exp Pathol; 2015; 8(1):842-6. PubMed ID: 25755784
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
7. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.
Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
Int J Clin Exp Pathol; 2014; 7(12):8881-6. PubMed ID: 25674259
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of CXCR4 and correlation with clinicopathological features and prognosis of non-small cell lung cancer patients: a meta-analysis.
Wang H; Xie F; Hu Z; Chen L
Genet Mol Res; 2015 Dec; 14(4):17893-903. PubMed ID: 26782435
[TBL] [Abstract][Full Text] [Related]
10. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of long noncoding RNA uc.338 predicts poor survival in non-small cell lung cancer.
Tian Y; Feng Y
Cancer Biomark; 2018; 22(4):781-785. PubMed ID: 29843223
[TBL] [Abstract][Full Text] [Related]
12. Mortalin overexpression predicts poor prognosis in early stage of non-small cell lung cancer.
Sun J; Che SL; Piao JJ; Xu M; Chen LY; Lin ZH
Tumour Biol; 2017 Mar; 39(3):1010428317695918. PubMed ID: 28349826
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer.
Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; Zhang CF
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126850
[TBL] [Abstract][Full Text] [Related]
14. MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.
Sun JZ; Zhang JH; Li JB; Yuan F; Tong LQ; Wang XY; Chen LL; Fan XG; Zhang YM; Ren X; Zhang C; Yu SP; Yang XJ
Dis Markers; 2021; 2021():6680883. PubMed ID: 34211612
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of FSCN1 in non-small cell lung cancer.
Luo A; Yin Y; Li X; Xu H; Mei Q; Feng D
Biomed Pharmacother; 2015 Jul; 73():75-9. PubMed ID: 26211585
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
[TBL] [Abstract][Full Text] [Related]
17. Expression and significance of myeloid differentiation factor 88 in non-small cell lung carcinoma and normal paracancerous tissues.
Zhu J; Li Q; He J; Ma K
Genet Mol Res; 2015 Nov; 14(4):14239-45. PubMed ID: 26600481
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-153 expression and prognosis in non-small cell lung cancer.
Chen WJ; Zhang EN; Zhong ZK; Jiang MZ; Yang XF; Zhou DM; Wang XW
Int J Clin Exp Pathol; 2015; 8(7):8671-5. PubMed ID: 26339455
[TBL] [Abstract][Full Text] [Related]
19. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
20. HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.
Wang Y; Li N; Che S; Jin T; Piao J; Liu S; Lin Z
Tumour Biol; 2017 Jul; 39(7):1010428317709675. PubMed ID: 28718367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
